APA
ARKG icon

American Portfolios Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

American Portfolios Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.73M Buy
52,651
+218
+0.4% +$8K 0.07% 273
2022
Q2 		$1.65M Sell
52,433
-2,692
-5% -$94.1K 0.07% 287
2022
Q1 		$2.53M Sell
55,125
-2,602
-5% -$124K 0.09% 243
2021
Q4 		$3.54M Sell
57,727
-1,964
-3% -$136K 0.12% 171
2021
Q3 		$4.46M Sell
59,691
-6,225
-9% -$522K 0.17% 114
2021
Q2 		$6.1M Sell
65,916
-1,804
-3% -$153K 0.24% 79
2021
Q1 		$6.01M Buy
67,720
+8,351
+14% +$828K 0.26% 75
2020
Q4 		$5.54M Buy
59,369
+5,402
+10% +$430K 0.28% 64
2020
Q3 		$3.44M Sell
53,967
-27,306
-34% -$1.6M 0.2% 102
2020
Q2 		$4.24M Buy
81,273
+66,308
+443% +$2.84M 0.28% 73
2020
Q1 		$468K Buy
14,965
+4,012
+37% +$134K 0.04% 385
2019
Q4 		$367K Buy
10,953
+1,609
+17% +$51.1K 0.03% 529
2019
Q3 		$276K Buy
9,344
+3,744
+67% +$122K 0.02% 586
2019
Q2 		$193K Buy
5,600
+1,526
+37% +$48.9K 0.02% 724
2019
Q1 		$134K Buy
4,074
+851
+26% +$25.1K 0.01% 765
2018
Q4 		$77.3K Sell
3,223
-1,228
-28% -$34.6K 0.01% 838
2018
Q3 		$149K Buy
4,451
+2,040
+85% +$64.6K 0.02% 684
2018
Q2 		$70.1K Buy
2,411
+100
+4% +$2.78K 0.01% 951
2018
Q1 		$59.5K Buy
2,311
+1,311
+131% +$35.5K 0.01% 945
2017
Q4 		$24.5K Buy
+1,000
New +$25.3K ﹤0.01% 1262

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

American Portfolios Advisors's ARKG Position: Q3 2022 in Review

American Portfolios Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 0.42% in Q3 2022, buying an estimated $8K and bringing the position to 52,651 shares worth $1.73M. The position accounts for 0.07% of the portfolio, ranked #273.

American Portfolios Advisors first reported a position in ARKG in Q4 2017 and has held it in 20 quarters since. The position peaked at $6.1M in Q2 2021. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

  • American Portfolios Advisors held 52,651 shares of ARK Genomic Revolution ETF worth $1.73M as of Q3 2022.
  • American Portfolios Advisors bought 218 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $8K.
  • ARK Genomic Revolution ETF made up 0.07% of American Portfolios Advisors's portfolio in Q3 2022, its #273 holding.
  • American Portfolios Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's ARK Genomic Revolution ETF position peaked at $6.1M in Q2 2021.
  • 311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.